What are Niagen Bioscience, Inc. Common Stock's profit margins?

Niagen Bioscience, Inc. Common Stock (NAGE) runs a 64.3% gross margin and a 10.0% operating margin, with a 14.3% net margin.

Where do Niagen Bioscience, Inc. Common Stock's ratios come from?

Every ratio is computed from Niagen Bioscience, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Niagen Bioscience, Inc. Common Stock NAGE Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	64.3%0.0pp	64.3%+0.4pp	63.9%+0.3pp	63.6%+1.1pp	62.5%+0.7pp
Operating margin	10%-2.5pp	12.6%-2.9pp	15.5%+1.1pp	14.3%+2.1pp	12.3%+4.5pp
Net margin	14.3%+0.9pp	13.4%-3.0pp	16.4%+1.1pp	15.2%+2.2pp	13.1%+4.5pp
EBITDA margin	10.7%-2.5pp	13.2%-2.9pp	16.1%+1.1pp	15%+2.0pp	13%+4.4pp
Returns
Return on equity	27.1%-1.3pp	28.3%-10.5pp	38.9%+1.5pp	37.4%+3.9pp	33.5%+10.5pp
Return on assets	19%-0.9pp	19.9%-6.5pp	26.4%+2.1pp	24.4%+3.5pp	20.8%+7.0pp
Return on invested capital	114.6%-52.8pp	167.3%-92.1pp	259.4%+10.8pp	248.6%-76.9pp	325.5%+56.9pp
Efficiency
Asset turnover	1.3×-0.1×	1.5×-0.1×	1.6×0.0×	1.6×0.0×	1.6×0.0×
Inventory turnover	2.6×-0.5×	3.1×+0.1×	3.1×-0.2×	3.3×-0.2×	3.4×+0.2×
Liquidity
Current ratio	4.6×-0.3×	4.9×+0.7×	4.1×+0.2×	3.9×+0.2×	3.7×+0.1×
Quick ratio	3.6×-0.3×	3.8×+0.5×	3.3×+0.1×	3.2×+0.1×	3.1×+0.1×
Cash ratio	2.9×-0.3×	3.3×+0.4×	2.8×+0.1×	2.7×0.0×	2.7×+0.2×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0.1×0.0×	0.1×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-4.6×-0.9×	-3.6×-0.6×	-3×+0.2×	-3.3×+0.4×	-3.7×+1.2×
Interest coverage	7.2×-1.4×	8.5×-1.4×	9.9×-0.1×	10×+0.2×	9.8×+3.0×
Per Share
Book value per share	$0.97+8.7%	$0.90+9.8%	$0.82+9.6%	$0.74+12.0%	$0.66+12.7%
Valuation
Market capitalization	$254.07M-74.9%	$507.57M-31.8%	$744.1M-33.1%	$1.11B—	——
Enterprise value	$190.09M-79.7%	$445.58M-34.7%	$682.86M-35.3%	$1.06B—	——
Price / earnings	13.6×-43.5×	29.2×-7.2×	36.4×-26.4×	62.8×—	——
Price / sales	2×-6.8×	3.9×-2.0×	6×-3.6×	9.6×—	——
Price / book	3.3×-13.6×	6.6×-3.9×	10.5×-6.8×	17.3×—	——
EV / EBITDA	15×-44.1×	26.1×-7.9×	34×-26.5×	60.5×—	——
EV / sales	1.6×-7.3×	3.4×-2.0×	5.5×-3.6×	9.1×—	——
Earnings yield	6.8%+5.2pp	3.4%+0.7pp	2.7%+1.2pp	1.6%—	——
PEG ratio	0.5×—	0.3×+0.3×	0×—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Niagen Bioscience, Inc. Common Stock.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Niagen Bioscience, Inc. Common Stock's profit margins?: Niagen Bioscience, Inc. Common Stock (NAGE) runs a 64.3% gross margin and a 10.0% operating margin, with a 14.3% net margin.
Where do Niagen Bioscience, Inc. Common Stock's ratios come from?: Every ratio is computed from Niagen Bioscience, Inc. Common Stock's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.